Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes
about
In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatusIn vitro renal toxicity and in vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with IntralipidAspergillus fumigatus and aspergillosisEffect of a highly concentrated lipopeptide extract of Bacillus subtilis on fungal and bacterial cells.Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycosesPreparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral Candida albicans.Activity of a heat-induced reformulation of amphotericin B deoxycholate (fungizone) against Leishmania donovaniMolecular umbrella-amphotericin B conjugates.Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholateIon channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy.Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.Serum pharmacology of amphotericin B applied in lipid emulsions.Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans.Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis.Amphotericin B is cytotoxic at locally delivered concentrationsCarrier effects on biological activity of amphotericin B.How can micelle systems be rebuilt by a heating process?Influence of diet on experimental toxicity of amphotericin B deoxycholate.Optimizing efficacy of amphotericin B through nanomodification.Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.Simple Strategy for Taming Membrane-Disrupting Antibiotics.Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.Synthesis and biological evaluation of amphotericin B derivatives.Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapySelf assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactanHeat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index.Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80.Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis.Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.Unique aggregation of conjugated amphotericin B and its interaction with lipid membranes.Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals.Pharmacokinetics and Renal Toxicity of Monomeric Amphotericin B in Rats after a Multiple Dose Regimen.Self-association of the polyene antibiotic nystatin in dipalmitoylphosphatidylcholine vesicles: a time-resolved fluorescence study.Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micellesReformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
P2860
Q28343158-723FC8F8-BFDA-4DF2-A1DD-9D8249E8F57EQ28369708-7B2E4C74-01AC-4597-9980-D9580F7BA3E8Q29617908-A11435FA-BE09-4E6E-83A9-84EF9563EE69Q33355024-229B9540-6492-424C-A5AB-9822A508E12FQ33749073-08A38DB7-261F-4509-93BF-62A3A35B3E12Q33749120-65D3EE59-9C66-4088-B3BF-CE91C0739B44Q33807138-BD94BDC3-6980-400A-A081-8B82C8526289Q33976111-57999CA0-B05A-46BE-8DA2-6A7BC40A517AQ34074786-F7B0942E-BFF3-49DA-8857-EB747B722E39Q34113525-C291E904-4968-4016-91A4-18F1FBB000C1Q34179391-666F0E64-EE0C-4D9B-BEBA-D9B5D9AED3A6Q35127147-DC43A8A9-858E-4F83-999B-5D9B1F6B9BB9Q35134565-98F06CBD-5538-4260-9F8A-0D55D0EEA697Q35138378-8C0CD539-14E5-45BD-AFF7-E73C466D5631Q35168703-1661A132-F71A-4144-8A68-BBB6226CC285Q35187151-1B371818-D84A-44D0-8AC8-C94803750A53Q35242794-163350C3-EB15-4B62-AFC6-5346E4A0DA11Q35372581-03D2AD1F-EEC2-4E46-93BD-2082B1EEAB71Q35686909-3E4E7DD9-3154-4430-9986-2DEDC9ADC335Q35820200-C6E2E1DC-5874-4B69-83E1-3DE77A21DAE3Q36920328-35EE56F3-A6DC-4E51-8978-537DBC33A873Q37005474-86B8AA54-2913-4429-89FD-0A6C6966DF93Q37532082-B69FEDCE-F146-44E1-9CAD-813AEF92DB0EQ37597619-5C0773C8-F662-4426-B259-4CAD55C0C0ADQ37765817-43DA4654-F868-486D-82E2-8A51EA39231DQ38342306-A8FC03AB-BD3F-4F5C-BB7B-27FCF70DD808Q38892819-6AE28F40-591F-4076-9A5F-6F08A836891FQ38937745-53D5CFF9-BA11-445E-B0A9-228646DBEEB5Q39294022-3227A9D9-4DE8-472B-8E49-C82940B8ED75Q39785217-C6E843D0-2CA2-47F1-A409-A8DCCF309D6DQ39954346-85B5D890-2EBA-47A7-B1B3-6446A4AAD1CDQ40163020-45D575A1-5CD9-4DEA-9109-AA4C61A73B45Q40187292-43667312-6BFF-43F3-AC08-C945443999E7Q40347592-0C6DBB82-6B90-410E-BB07-6E30DBC79EABQ40851105-A0FD0207-0111-466B-AF98-EA64449D3DDCQ41703512-33F9D5CF-47D0-4B00-98B5-097160CA9089Q41786957-4772A1DF-D982-4989-9BEC-7829977A18E9Q41853685-6809BBB5-C268-4A6F-88D5-24DF18665D75Q41915894-07780DEE-DF7B-4D65-BAD2-2BE39AE0B4C0Q42391942-16FC979D-3DE9-4094-BF8F-F10274C7CD44
P2860
Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Effects of aggregation and sol ...... ericin B to human erythrocytes
@ast
Effects of aggregation and sol ...... ericin B to human erythrocytes
@en
type
label
Effects of aggregation and sol ...... ericin B to human erythrocytes
@ast
Effects of aggregation and sol ...... ericin B to human erythrocytes
@en
prefLabel
Effects of aggregation and sol ...... ericin B to human erythrocytes
@ast
Effects of aggregation and sol ...... ericin B to human erythrocytes
@en
P2093
P2860
P356
P1476
Effects of aggregation and sol ...... ericin B to human erythrocytes
@en
P2093
P2860
P304
P356
10.1128/AAC.36.11.2518
P407
P577
1992-11-01T00:00:00Z